The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

REDEL Trial: Reduced Elective Nodal Dose for Anal Cancer Toxicity Mitigation (REDEL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05902533
Recruitment Status : Recruiting
First Posted : June 15, 2023
Last Update Posted : February 23, 2024
Information provided by (Responsible Party):
Jordan Kharofa, University of Cincinnati

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 14, 2026
Estimated Study Completion Date : August 14, 2029